Analysis of blood tumor markers detected increased levels of SCC-Ag, CYFRA21-1, and CEA [6,15,16,17] in patients with squamous cell carcinoma of the lung, compared to those who presented with adenocarcinoma [15]. This evidence concerns the gene CEACAM5 and neoplasm.